Agilon Health price target lowered to $2 from $7 at Stifel
The Fly

Agilon Health price target lowered to $2 from $7 at Stifel

Stifel lowered the firm’s price target on Agilon Health (AGL) to $2 from $7 and keeps a Hold rating on the shares. Agilon has traded down 23% since the Q3 report and the firm expects it to remain depressed until it proves it can expand medical margin and accurately project medical expenses after the company’s profitability guidance was lowered significantly.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App